Report cover image

Peripheral Nerve Stimulators Market Size, Share & Trends Analysis Report By Product (Systems, Wearables/Accessories), By Modality (Rechargeable, Non-Rechargeable), By Application (Diabetic Peripheral Neuropathy Pain), By Connectivity, By End Use, By Regio

Publisher Grand View Research
Published Sep 25, 2025
Length 300 Pages
SKU # GV20471147

Description

Peripheral Nerve Stimulators Market Summary

The global peripheral nerve stimulators market size was estimated at USD 271.79 million in 2024 and is projected to reach USD 680.30 million by 2033, growing at a CAGR of 10.89% from 2025 to 2033. The rising prevalence of chronic pain disorders, increasing preference for minimally invasive and non-opioid therapies, and continuous advancements in neuromodulation technologies are the primary driving factors contributing to the growth of the industry.

The rising prevalence of chronic pain disorders is one of the key driving factors of the peripheral nerve stimulators industry. Conditions like neuropathic pain, migraines, and post-surgical pain often cause long-term disability, while traditional treatments such as opioids carry risks of addiction and limited efficacy. For instance, according to recent data published by Brain Research UK, the following facts and statistics highlight the burden of neurological conditions in the UK:

Global Peripheral Nerve Stimulators Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global peripheral nerve stimulators market report based on product, modality, connectivity, application, end use, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Systems
  • Implantable
  • Non-implantable
  • Handheld
  • Others
  • Wearables/Accessories
  • Modality Outlook (Revenue, USD Million, 2021 - 2033)
  • Rechargeable
  • Non-rechargeable
  • Connectivity Outlook (Revenue, USD Million, 2021 - 2033)
  • Wired
  • Wireless
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Diabetic Peripheral Neuropathy Pain
  • Chronic Musculoskeletal Pain
  • Complex Regional Pain Syndrome (CRPS)
  • Headache and migraine disorders
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Physiotherapy/Rehabilitation Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

300 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product Type
1.1.2. Modality
1.1.3. Application
1.1.4. Connectivity
1.1.5. End-use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Peripheral Nerve Stimulators Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of chronic pain disorders
3.2.1.2. Growing preference for minimally invasive therapies
3.2.1.3. Opioid crisis and shift toward non-opioid pain management
3.2.1.4. Expanding applications beyond chronic pain
3.2.2. Market restraint analysis
3.2.2.1. High cost of devices and procedures
3.2.2.2. Risk of complications and device-related issues
3.2.3. Market opportunity analysis
3.2.3.1. Expansion into new indications
3.2.3.2. Adoption in outpatient & home-care settings
3.2.3.3. Rising demand for personalized pain management
3.2.4. Market challenge analysis
3.2.4.1. Competition from alternative therapies
3.2.4.2. Patient selection challenges
3.3. Peripheral Nerve Stimulators Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitutes
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
Chapter 4. Peripheral Nerve Stimulators Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Peripheral Nerve Stimulators Market Product Movement Analysis
4.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Systems
4.4.1. Systems market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.1. Implantable
4.4.1.1.1. Implantable market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.2. Non-implantable
4.4.1.2.1. Non-implantable market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.2.1.1. Handheld
4.4.1.2.1.1.1. Handheld market estimates and forecasts for 2021 to 2033 (USD Million)
4.4.1.2.1.2. Others
4.4.1.2.1.1.1. Handheld market estimates and forecasts for 2021 to 2033 (USD Million)
4.5. Wearables/Accessories
4.5.1. Wearables/Accessories market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 5. Peripheral Nerve Stimulators Market: Modality Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Peripheral Nerve Stimulators Market Modality Movement Analysis
5.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Modality, 2021 to 2033 (USD Million)
5.4. Rechargeable
5.4.1. Rechargeables market estimates and forecasts for 2021 to 2033 (USD Million)
5.5. Non-Rechargeable
5.5.1. Non-rechargeable market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 6. Peripheral Nerve Stimulators Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Peripheral Nerve Stimulators Market Application Movement Analysis
6.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Diabetic Peripheral Neuropathy Pain
6.4.1. Diabetic peripheral neuropathy pain market estimates and forecasts for 2021 to 2033 (USD Million)
6.5. Chronic Musculoskeletal Pain
6.5.1. Chronic musculoskeletal pain market estimates and forecasts for 2021 to 2033 (USD Million)
6.6. Complex Regional Pain Syndrome (CRPS)
6.6.1. Complex regional pain syndrome (CRPS) market estimates and forecasts for 2021 to 2033 (USD Million)
6.7. Headache and Migraine Disorders
6.7.1. Headache and migraine disorders market estimates and forecasts for 2021 to 2033 (USD Million)
6.8. Others
6.8.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 7. Peripheral Nerve Stimulators Market: Connectivity Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Peripheral Nerve Stimulators Market Connectivity Movement Analysis
7.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by Connectivity, 2021 to 2033 (USD Million)
7.4. Wired
7.4.1. Wired market estimates and forecasts for 2021 to 2033 (USD Million)
7.5. Wireless
7.5.1. Wireless market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 8. Peripheral Nerve Stimulators: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Global Peripheral Nerve Stimulators Market End Use Movement Analysis
8.3. Global Peripheral Nerve Stimulators Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
8.4. Hospitals and Clinics
8.4.1. Hospitals and Clinics market estimates and forecasts for 2021 to 2033 (USD Million)
8.5. Ambulatory Surgical Centers (ASCs)
8.5.1. Specialty clinics market estimates and forecasts for 2021 to 2033 (USD Million)
8.6. Physiotherapy/Rehabilitation Centers
8.6.1. Ambulatory surgery centers market estimates and forecasts for 2021 to 2033 (USD Million)
8.7. Others
8.7.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
Chapter 9. Peripheral Nerve Stimulators Market: Regional Estimates & Trend Analysis
9.1. Regional Dashboard
9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
9.3. North America
9.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. Key country dynamics
9.3.2.2. Competitive scenario
9.3.2.3. Regulatory framework
9.3.2.4. Reimbursement scenario
9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
9.3.3. Canada
9.3.3.1. Key country dynamics
9.3.3.2. Competitive scenario
9.3.3.3. Regulatory framework
9.3.3.4. Reimbursement scenario
9.3.3.5. Canada market estimates and forecasts, 2021 - 2033
9.3.4. Mexico
9.3.4.1. Key country dynamics
9.3.4.2. Competitive scenario
9.3.4.3. Regulatory framework
9.3.4.4. Reimbursement scenario
9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
9.4. Europe
9.4.1. UK
9.4.1.1. Key country dynamics
9.4.1.2. Competitive scenario
9.4.1.3. Regulatory framework
9.4.1.4. Reimbursement scenario
9.4.1.5. UK market estimates and forecasts, 2021 - 2033
9.4.2. Germany
9.4.2.1. Key country dynamics
9.4.2.2. Competitive scenario
9.4.2.3. Regulatory framework
9.4.2.4. Reimbursement scenario
9.4.2.5. Germany market estimates and forecasts, 2021 - 2033
9.4.3. France
9.4.3.1. Key country dynamics
9.4.3.2. Competitive scenario
9.4.3.3. Regulatory framework
9.4.3.4. Reimbursement scenario
9.4.3.5. France market estimates and forecasts, 2021 - 2033
9.4.4. Italy
9.4.4.1. Key country dynamics
9.4.4.2. Competitive scenario
9.4.4.3. Regulatory framework
9.4.4.4. Reimbursement scenario
9.4.4.5. Italy market estimates and forecasts, 2021 - 2033
9.4.5. Spain
9.4.5.1. Key country dynamics
9.4.5.2. Competitive scenario
9.4.5.3. Regulatory framework
9.4.5.4. Reimbursement scenario
9.4.5.5. Spain market estimates and forecasts, 2021 - 2033
9.4.6. Denmark
9.4.6.1. Key country dynamics
9.4.6.2. Competitive scenario
9.4.6.3. Regulatory framework
9.4.6.4. Reimbursement scenario
9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
9.4.7. Sweden
9.4.7.1. Key country dynamics
9.4.7.2. Competitive scenario
9.4.7.3. Regulatory framework
9.4.7.4. Reimbursement scenario
9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
9.4.8. Norway
9.4.8.1. Key country dynamics
9.4.8.2. Competitive scenario
9.4.8.3. Regulatory framework
9.4.8.4. Reimbursement scenario
9.4.8.5. Norway market estimates and forecasts, 2021 - 2033
9.5. Asia Pacific
9.5.1. Japan
9.5.1.1. Key country dynamics
9.5.1.2. Competitive scenario
9.5.1.3. Regulatory framework
9.5.1.4. Reimbursement scenario
9.5.1.5. Japan market estimates and forecasts, 2021 - 2033
9.5.2. India
9.5.2.1. Key country dynamics
9.5.2.2. Competitive scenario
9.5.2.3. Regulatory framework
9.5.2.4. Reimbursement scenario
9.5.2.5. India market estimates and forecasts, 2021 - 2033
9.5.3. China
9.5.3.1. Key country dynamics
9.5.3.2. Competitive scenario
9.5.3.3. Regulatory framework
9.5.3.4. Reimbursement scenario
9.5.3.5. China market estimates and forecasts, 2021 - 2033
9.5.4. South Korea
9.5.4.1. Key country dynamics
9.5.4.2. Competitive scenario
9.5.4.3. Regulatory framework
9.5.4.4. Reimbursement scenario
9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
9.5.5. Australia
9.5.5.1. Key country dynamics
9.5.5.2. Competitive scenario
9.5.5.3. Regulatory framework
9.5.5.4. Reimbursement scenario
9.5.5.5. Australia market estimates and forecasts, 2021 - 2033
9.5.6. Thailand
9.5.6.1. Key country dynamics
9.5.6.2. Competitive scenario
9.5.6.3. Regulatory framework
9.5.6.4. Reimbursement scenario
9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
9.6. Latin America
9.6.1. Brazil
9.6.1.1. Key country dynamics
9.6.1.2. Competitive scenario
9.6.1.3. Regulatory framework
9.6.1.4. Reimbursement scenario
9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
9.6.2. Argentina
9.6.2.1. Key country dynamics
9.6.2.2. Competitive scenario
9.6.2.3. Regulatory framework
9.6.2.4. Reimbursement scenario
9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
9.7. MEA
9.7.1. South Africa
9.7.1.1. Key country dynamics
9.7.1.2. Competitive scenario
9.7.1.3. Regulatory framework
9.7.1.4. Reimbursement scenario
9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
9.7.2. Saudi Arabia
9.7.2.1. Key country dynamics
9.7.2.2. Competitive scenario
9.7.2.3. Regulatory framework
9.7.2.4. Reimbursement scenario
9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
9.7.3. UAE
9.7.3.1. Key country dynamics
9.7.3.2. Competitive scenario
9.7.3.3. Regulatory framework
9.7.3.4. Reimbursement scenario
9.7.3.5. UAE market estimates and forecasts, 2021 - 2033
9.7.4. Kuwait
9.7.4.1. Key country dynamics
9.7.4.2. Competitive scenario
9.7.4.3. Regulatory framework
9.7.4.4. Reimbursement scenario
9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.2.1. Innovators
10.3. Vendor Landscape
10.3.1. List of key distributors and channel partners
10.3.2. Key customers
10.3.3. Global Key company market share analysis, 2024
10.3.4. B. Braun SE
10.3.4.1. Company overview
10.3.4.2. Financial performance
10.3.4.3. Product Type benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Nalu Medical, Inc.
10.3.5.1. Company overview
10.3.5.2. Financial performance
10.3.5.3. Product Type benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Curonix LLC.
10.3.6.1. Company overview
10.3.6.2. Financial performance
10.3.6.3. Product Type benchmarking
10.3.6.4. Strategic initiatives
10.3.7. SPR
10.3.7.1. Company overview
10.3.7.2. Financial performance
10.3.7.3. Product Type benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Vygon
10.3.8.1. Company overview
10.3.8.2. Financial performance
10.3.8.3. Product Type benchmarking
10.3.8.4. Strategic initiatives
10.3.9. AirLife
10.3.9.1. Company overview
10.3.9.2. Financial performance
10.3.9.3. Product Type benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Neuspera Medical
10.3.10.1. Company overview
10.3.10.2. Financial performance
10.3.10.3. Product Type benchmarking
10.3.10.4. Strategic initiatives
10.3.11. AVNS
10.3.11.1. Company overview
10.3.11.2. Financial performance
10.3.11.3. Product Type benchmarking
10.3.11.4. Strategic initiatives
10.3.12. Mercury Medical
10.3.12.1. Company overview
10.3.12.2. Financial performance
10.3.12.3. Product Type benchmarking
10.3.12.4. Strategic initiatives
10.3.13. Medilogix
10.3.13.1. Company overview
10.3.13.2. Financial performance
10.3.13.3. Product Type benchmarking
10.3.13.4. Strategic initiatives
10.3.14. Anesthesia Associates, Inc.
10.3.14.1. Company overview
10.3.14.2. Financial performance
10.3.14.3. Product Type benchmarking
10.3.14.4. Strategic initiatives
10.3.15. Medtronic
10.3.15.1. Company overview
10.3.15.2. Financial performance
10.3.15.3. Product Type benchmarking
10.3.15.4. Strategic initiatives
10.3.16. Boston Scientific Corporation
10.3.16.1. Company overview
10.3.16.2. Financial performance
10.3.16.3. Product Type benchmarking
10.3.16.4. Strategic initiatives
10.3.17. Abbott
10.3.17.1. Company overview
10.3.17.2. Financial performance
10.3.17.3. Product Type benchmarking
10.3.17.4. Strategic initiatives
10.3.18. Bioventus
10.3.18.1. Company overview
10.3.18.2. Financial performance
10.3.18.3. Product Type benchmarking
10.3.18.4. Strategic initiatives
10.3.19. Checkpoint Surgical Inc.
10.3.19.1. Company overview
10.3.19.2. Financial performance
10.3.19.3. Product Type benchmarking
10.3.19.4. Strategic initiatives
10.3.20. NEURIMPULSE s.r.l.
10.3.20.1. Company overview
10.3.20.2. Financial performance
10.3.20.3. Product Type benchmarking
10.3.20.4. Strategic initiatives
10.3.21. Nervonik, Inc
10.3.21.1. Company overview
10.3.21.2. Financial performance
10.3.21.3. Product Type benchmarking
10.3.21.4. Strategic initiatives
10.3.22. Epineuron Technologies Inc.
10.3.22.1. Company overview
10.3.22.2. Financial performance
10.3.22.3. Product Type benchmarking
10.3.22.4. Strategic initiatives
10.4. Heat Map Analysis/ Company Market Position Analysis
10.5. Estimated Company Market Share Analysis, 2024
10.6. List of Other Key Market Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us